PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsOxcarbazepine
Oxcarbazepine
Oxcarbazepine, Oxtellar, Trileptal (oxcarbazepine) is a small molecule pharmaceutical. Oxcarbazepine was first approved as Trileptal on 2000-01-14. It is used to treat epilepsy and partial epilepsies in the USA.
Download report
Favorite
Novartis Pharmaceuticals
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
Trade Name
FDA
EMA
Oxcarbazepine, Oxtellar, Trileptal (discontinued: Oxcarbazepine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oxcarbazepine
Tradename
Company
Number
Date
Products
TRILEPTALNovartisN-021014 RX2000-01-14
3 products, RLD, RS
TRILEPTALNovartisN-021285 RX2001-05-25
1 products, RLD, RS
OXTELLAR XRSupernus PharmaceuticalsN-202810 RX2012-10-19
3 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
oxcarbazepineANDA2025-05-02
oxtellar xrNew Drug Application2024-10-10
trileptalNew Drug Application2025-01-21
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
epilepsyEFO_0000474D004827G40.9
partial epilepsiesEFO_0004263D004828—
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Oxcarbazepine, Oxtellar Xr, Supernus Pharms
77228982027-04-13DP
79101312027-04-13U-2041
86176002027-04-13DP
88219302027-04-13DP
91197912027-04-13U-2041
93519752027-04-13DP
93705252027-04-13DP
98552782027-04-13DP
102200422027-04-13U-2501
111669602027-04-13DP
118965992027-04-13DP
ATC Codes
N: Nervous system drugs
— N03: Antiepileptics
— N03A: Antiepileptics
— N03AF: Carboxamide derivatives, antiepileptics
— N03AF02: Oxcarbazepine
HCPCS
No data
Clinical
Clinical Trials
69 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
EpilepsyD004827EFO_0000474G40.91—2—14
Partial epilepsiesD004828EFO_0004263—1—2——3
SeizuresD012640—G40.4——1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOxcarbazepine
INNoxcarbazepine
Description
Oxcarbazepine is a dibenzoazepine derivative, having a carbamoyl group at the ring nitrogen, substituted with an oxo group at C-4 of the azepeine ring which is also hydrogenated at C-4 and C-5. It is a anticholinergic anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy. It has a role as an anticonvulsant and a drug allergen. It is a dibenzoazepine and a cyclic ketone. It contains a carbamoyl group.
Classification
Small molecule
Drug classtricyclic compounds
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
NC(=O)N1c2ccccc2CC(=O)c2ccccc21
Identifiers
PDB—
CAS-ID28721-07-5
RxCUI—
ChEMBL IDCHEMBL1068
ChEBI ID7824
PubChem CID34312
DrugBankDB00776
UNII IDVZI5B1W380 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Oxtellar – Supernus Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Oxcarbazepine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 8,550 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
17,311 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use